廖采枫
Lv31
210 积分
2021-10-28 加入
-
Predicting protein-protein interactions in the human proteome
3小时前
已完结
-
Application of Empirical Scalars To Enable Early Prediction of Human Hepatic Clearance Using In Vitro-In Vivo Extrapolation in Drug Discovery: An Evaluation of 173 Drugs
23天前
已完结
-
The pharmacological basis for nonpeptide agonism of the GLP-1 receptor by orforglipron
1个月前
已完结
-
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
1个月前
已完结
-
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
1个月前
已完结
-
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
1个月前
已完结
-
GZR18, a novel long-acting GLP-1 analog, demonstrated positive in vitro and in vivo pharmacokinetic and pharmacodynamic characteristics in animal models
3个月前
已完结
-
Derivatization with fatty acids in peptide and protein drug discovery
7个月前
已完结
-
Activation of innate immune cGAS-STING pathway contributes to Alzheimer’s pathogenesis in 5×FAD mice
11个月前
已完结
-
Chemistry of Metabolites of Thioureas
1年前
已完结